Nanosilver alleviates foreign body reaction and facilitates wound repair by regulating macrophage polarization
Open accessAbstract
Foreign body reactions induced by macrophages often cause delay or failure of wound healing in the application of tissue engineering scaffolds. This study explores the application of nanosilver (NAg) to reduce foreign body reactions during scaffold transplantation. An NAg hybrid collagen-chitosan scaffold (NAg-CCS) was prepared using the freeze-drying method. The NAg-CCS was implanted on the back of rats to evaluate the effects on foreign body reactions. Skin tissue samples were collected for histological and immunological evaluation at variable intervals. Miniature pigs were used to assess the effects of NAg on skin wound healing. The wounds were photographed, and tissue samples were collected for molecular biological analysis at different time points post-transplantation. NAg-CCS has a porous structure and the results showed that it could release NAg constantly for two weeks. The NAg-CCS group rarely developed a foreign body reaction, while the blank-CCS group showed granulomas or necrosis in the subcutaneous grafting experiment. Both matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were reduced significantly in the NAg-CCS group. The NAg-CCS group had higher interleukin (IL)-10 and lower IL-6 than the blank CCS group. In the wound healing study, M1 macrophage activation and inflammatory-related proteins (inducible nitric oxide synthase (iNOS), IL-6, and interferon-γ (IFN-γ)) were inhibited by NAg. In contrast, M2 macrophage activation and proinflammatory proteins (arginase-1, major histocompatibility complex-II (MHC-II), and found in inflammatory zone-1 (FIZZ-1)) were promoted, and this was responsible for suppressing the foreign body responses and accelerating wound healing. In conclusion, dermal scaffolds containing NAg suppressed the foreign body reaction by regulating macrophages and the expression of inflammatory cytokines, thereby promoting wound healing.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
38 of 50 cited sources checked · 4 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Overactive M1 macrophages can activate M2 macrophages intensively, resulting in a subsequent proliferation of fibrous tissues surrounding the scaffold and aggravating the formation of foreign body granulomas.
“Besides, overactive M1 macrophages can also activate M2 macrophages intensively, resulting in a subsequent proliferation of fibrous tissues surrounding the scaffold and aggravating the formation of foreign body granulomas (Anderson et al., 2008;Witherel et al., 2021).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Anderson et al., 2008 source
Section 3.1.2 (page unavailable) says alternatively activated macrophages promote fibrogenesis and that biomaterial-adherent macrophages can contribute to a fibrous capsule. Sections 3.1 and 3.2 (pages unavailable) instead describe IL-4 and IL-13 as drivers of alternative activation and foreign body giant-cell formation. The copy does not say overactive M1 macrophages activate M2 macrophages or that this sequence aggravates foreign body granulomas. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Witherel et al., 2021 source
The Introduction links both M1- and M2-associated signals to fibrosis, and the Results (Effects of IL4+IL13 release on fibrous capsule properties; page unavailable) report increased matrix deposition around hydrogels given M2-promoting cytokines. But the paper does not show overactive M1 macrophages activating M2 macrophages or establish that this sequence aggravates foreign body granulomas; the reported increase in capsule thickness was only a trend. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Uncontrolled infection or inflammation at the early stage of implantation may lead to foreign body reactions and granuloma formation, which suppresses the physiological process of skin wound healing.
“As a result, uncontrolled infection or inflammation at the early stage of implantation may lead to foreign body reactions and granuloma formation, which suppresses the physiological process of skin wound healing”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Huang et al., 2018 source
- cites Benayahu et al., 2020 source
The Results (§2; page not provided) describe inflammatory cells and giant cells as an expected response to the implanted material. The paper does not say that uncontrolled early infection or inflammation causes granulomas or suppresses skin wound healing; its Discussion (§3) instead describes the observed response as part of healing. Its reference to granulation tissue is not evidence of granuloma formation. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
Our previous studies demonstrated that NAg-CCS was favorable and applicable for treating burn wounds.
“Our previous studies demonstrated that nanosilver (NAg)-loaded collagen-chitosan scaffold (NAg-CCS) was favorable and applicable for treating burn wounds.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites You et al., 2012 source
The Wound therapy section (page unavailable) says silver-nanoparticle dressings may reduce infection and accelerate healing in second-degree burns. It discusses other silver-containing scaffolds, but does not identify or report findings for the specific nanosilver-loaded collagen-chitosan scaffold (NAg-CCS), so it cannot establish that prior studies found NAg-CCS favorable for treating burns. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites You et al., 2017 source
The Results section reports faster epithelialization and smaller residual wound areas with NAg-CCS than with CCS. However, the Methods describe surgically excised full-thickness wounds in rats, not burn wounds. The study supports NAg-CCS as promising for wound healing, but does not demonstrate its applicability specifically to burns. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Macrophages and giant cells are activated and accumulate when medical devices, prostheses, or biomaterials are implanted.
“Macrophages and giant cells will be activated and initiated to accumulate when medical devices, prostheses, or biomaterials are implanted”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Sheikh et al., 2015 source
- Premisecitation
Apart from antimicrobial effects, NAg-loaded scaffolds can also inhibit the abnormal inflammatory response effectively.
“Apart from their antimicrobial effects, NAg-loaded scaffolds can also inhibit the abnormal inflammatory response effectively”
Quote in the paperSubstantial claim2 of 2 sources checked- cites You et al., 2012 source
The Anti-inflammatory uses section reports that nano-crystalline silver dressings may aid wound healing through anti-inflammatory activity and that silver cream suppresses inflammatory markers. The Wound therapy section reports antibacterial effects for silver-loaded scaffolds, but does not show that those scaffolds effectively inhibit an abnormal inflammatory response. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites You et al., 2017 source
- Premisecitation
Foreign body reactions conducted by macrophages often lead to local granulomatosis, which affects the lifespan of implants and causes delay or suspension of wound repair.
“Foreign body reactions conducted by macrophages often lead to local granulomatosis, which not only affects the lifespan of the implants but also causes delay or even suspension of the wound repair process”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Anderson et al., 2008 source
The Introduction (page unavailable) describes macrophages and foreign body giant cells at the implant interface, and section 2.4 reports that their activity can degrade biomaterials and lead to device failure. The paper describes granulation tissue, not local granulomatosis, and the passages found do not say that the reaction delays or suspends wound repair. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites Sheikh et al., 2015 source
The Introduction (page unavailable) identifies macrophages and foreign body giant cells as components of the foreign body reaction, and the Abstract says that reaction may affect implant biocompatibility and long-term success. Section 6 (page unavailable) describes lengthened wound-healing phases and persistent inflammation, supporting delayed repair. The paper does not say these reactions often cause local granulomatosis or suspend wound repair; its mention of granulomatous disease is an association with multinucleated giant cells, not that outcome. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites Chiang et al., 2017 source
- Premisecitation
M1-type macrophages gradually fuse with implants and develop into foreign-body giant cells following the initiation of phagocytosis.
“These M1-type macrophages gradually fuse with the implants and develop into foreign-body giant cells following the initiation of phagocytosis”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Sheikh et al., 2015 source
Section 5 says macrophages can fuse into foreign-body giant cells at the biomaterial–tissue interface, and Section 7 describes their response to particles too large for one macrophage to engulf. The paper does not specify that these are M1-type macrophages or that they fuse with implants: macrophages fuse with one another. Section 7 describes the resulting giant cells attempting to engulf large particles, rather than fusion following the initiation of phagocytosis. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Anderson and Jiang, 2017 source
- Premisecitation
Mast cells recruit macrophages through degranulation and histamine secretion, contributing to the development of the foreign body reaction.
“Mast cells also recruit macrophages through degranulation and histamine secretion, contributing to the development of the foreign body reaction”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites Anderson et al., 2008 source
- cites Shi et al., 2018 source
The Introduction and Discussion (pages not supplied) address keloid fibroblasts, miR-203, and extracellular matrix production, not mast cells or the foreign body reaction. Searches for mast-cell recruitment, degranulation, histamine, and macrophages found no passage addressing the claim. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites Villarreal-Leal et al., 2021 source
- Premisecitation
The leading protagonist involved in the foreign body reaction is classically activated M1 macrophages.
“The leading protagonist involved in the foreign body reaction is classically activated M1 macrophages”
Quote in the paperSubstantial claim1 of 1 sources checked- cites O 'Shea et al., 2020 source
The Results section, “Hydrogel FBRs differ in inflammatory cell recruitment/persistence” (page not available), reports macrophage-lineage cells in some foreign body responses. It does not identify them as classically activated M1 macrophages or establish them as the leading cell type; other responses included substantial neutrophil infiltration. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
The relative quantification of CD68 and CD163 proteins roughly distinguishes the activation of M1 and M2 macrophages.
“The relative quantification of CD68 and CD163 proteins roughly distinguishes the activation of M1 and M2 macrophages (Vannella and Wynn, 2017;Huang et al., 2018;Kim et al., 2019).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Vannella and Wynn, 2017 source
In “Polarizing Toward Repair” (page not provided), the paper mentions CD68-positive macrophages but does not identify CD68 as an M1 marker; it describes the protective macrophages as neither M(IFN-γ)- nor M(IL-4)-like. Searches for CD163 and for relative CD68/CD163 quantification found no passage establishing that the two proteins distinguish M1 from M2 activation. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites Huang et al., 2018 source
- cites Kim et al., 2019 source
The Results and Discussion section (page unavailable) uses protein markers to distinguish M1 from M2 macrophages, reporting CD86 and iNOS for M1 and Arginase and CD206 for M2. It does not identify CD68 or CD163 as the proteins for that distinction or compare their relative quantities. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
M1 macrophages secrete numerous proteolytic enzymes to degrade extracellular matrix (ECM), including collagens, elastin, and fibronectin.
“M1 macrophages secrete numerous proteolytic enzymes to degrade extracellular matrix (ECM), including collagens, elastin, and fibronectin.”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Wynn and Vannella, 2016 source
The Introduction says macrophages produce matrix metalloproteinases, and “Regulation and function of pro-fibrotic macrophages” says these enzymes degrade ECM proteins and identifies a macrophage-secreted elastase. The paper does not assign this activity specifically to M1 macrophages or explicitly identify collagen and fibronectin as substrates. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites Hesketh et al., 2017 source
The Introduction (page unavailable) says macrophages can release enzymes that alter ECM composition. Section 5.1 (page unavailable) describes excessive ECM proteolysis in chronic wounds, but attributes altered MMP secretion to dermal fibroblasts, not M1 macrophages. The copy does not establish that M1 macrophages secrete numerous proteolytic enzymes or identify collagen, elastin, and fibronectin as their targets. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites Liu et al., 2021 source
The paper’s discussion of extracellular matrix concerns mineralization during MOF-assisted bone formation, not degradation by macrophages (section: Metal-organic framework (MOF)-based biomaterials in bone tissue engineering; page unavailable). Searches for M1 macrophages, proteolytic enzymes, and ECM degradation found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
M2 macrophages secrete ECM cross-linking enzymes, such as glutaminyl transferase and osteopontin, which promote ECM and cell adhesion.
“M2 macrophages secrete ECM cross-linking enzymes, such as glutaminyl transferase and osteopontin, which promote ECM and cell adhesion”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Wynn and Vannella, 2016 source
The section “Regulation and function of pro-fibrotic macrophages” (page unavailable) says M(IL-4) macrophages regulate collagen fibril assembly and that loss of IL-4Rα signaling diminishes induction of lysyl hydroxylase 2, an enzyme involved in collagen cross-links. It does not say these macrophages secrete glutaminyl transferase or osteopontin, or that those substances promote ECM and cell adhesion. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Hesketh et al., 2017 source
Section 4 (page unavailable) says M2 macrophages secrete TGF-β1, which stimulates fibroblasts that produce wound collagen. It does not say they secrete glutaminyl transferase or osteopontin, or that these substances cross-link ECM and promote ECM and cell adhesion. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites Liu et al., 2021 source
The paper’s discussion of MOF-based cell-culture substrates describes cell adhesion, and its discussion of ZIF-8 hydrogels describes crosslinking through catechol–zinc interactions. Neither passage addresses M2 macrophages secreting glutaminyl transferase or osteopontin. Searches for those terms and for macrophage-mediated ECM cross-linking found no supporting passage in our copy; page numbers were unavailable. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Both M1 and M2 macrophages play important roles in collagen deposition.
“suggesting that both macrophages play important roles in collagen deposition (Wynn and Vannella, 2016;Hesketh et al., 2017;Liu et al., 2021).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Wynn and Vannella, 2016 source
In “Regulation and function of pro-fibrotic macrophages” (page not available), the review says collagen fibril assembly during skin repair depends on M(IL-4) macrophages, broadly corresponding to M2. It also says inflammatory monocytes can promote fibrosis, but does not establish that M1 macrophages play an important role in collagen deposition specifically. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites Hesketh et al., 2017 source
Section 4 links M2 macrophages to collagen production through their effects on fibroblasts and myofibroblasts. The Summary (section 6) likewise assigns this collagen-related role to M2 cells; it discusses M1 cells as affecting inflammation and repair, but does not establish that M1 cells play an important role in collagen deposition. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Liu et al., 2021 source
The paper’s bone-tissue-engineering discussion describes MOF scaffolds, osteogenesis, and extracellular-matrix mineralization, but does not address M1 or M2 macrophages’ roles in collagen deposition. Searches for macrophages, collagen deposition, and macrophage polarization found no passage supporting the attributed point; page numbers were not available in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Findingown data
In the miniature pig wound model, on postoperative Day 28, the NAg-CCS group had more prominent epithelization and healing rate.
“On postoperative Day 28, the NAg-CCS group had a more prominent epithelization and healing rate.”
Quote in the paperSubstantial claim - Findingown data
In the rat subcutaneous implantation, the number of IL-10-positive cells (M2 macrophages) on Day 3 was not significantly different between NAg-CCS and blank CCS groups.
“the number of IL-10-positive cells (M2 macrophages) on Day 3 after scaffold implantation in the NAg-CCS group was not significantly different from that of the blank CCS group”
Quote in the paperNot a substantial claim- Rests on an assumption: IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
- Findingown data
In the rat subcutaneous implantation, the blank CCS group had significantly higher tissue expression of MMP-1 and TIMP-1 than the NAg-CCS group.
“Both matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were reduced significantly in the NAg-CCS group.”
- Also stated in: § 3.2 Subcutaneous implantation of scaffolds in rats · plain
“IHC showed that the blank CCS group had significantly higher tissue expression of MMP-1 and TIMP-1 (Figs. 2b-2d) than the NAg-CCS group.”
Quote in the paperSubstantial claim - Also stated in: § 3.2 Subcutaneous implantation of scaffolds in rats · plain
- Findingown data
In the rat subcutaneous implantation, qRT-PCR showed IL-6 expression in the NAg-CCS group on both days was significantly inhibited compared with the blank CCS group.
“the expression of IL-6 in the NAg-CCS group on both days was significantly inhibited compared with that in the blank CCS group”
Quote in the paperSubstantial claim - Findingown data
In the rat subcutaneous implantation, the number of IL-6-positive cells (M1 macrophages) on Days 3 and 7 was much lower in the NAg-CCS group than in the blank CCS group.
“the number of IL-6-positive cells (M1 macrophages) on Days 3 and 7 after scaffold implantation in the NAg-CCS group was much lower than that in the blank CCS group”
Quote in the paperSubstantial claim- Rests on an assumption: IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
- Findingown data
The degradation rate of the scaffolds was not significantly altered after nanoparticle encapsulation.
“Subsequent degradation experiments showed that the degradation rate of the scaffolds was not significantly altered after nanoparticle encapsulation”
Quote in the paperNot a substantial claim - Findingown data
In the rat subcutaneous implantation, on Day 7 the number of IL-10-positive cells (M2 macrophages) was significantly higher in the NAg-CCS group than in the blank CCS group.
“On Day 7 after scaffold implantation, the number of IL-10-positive cells in the NAg-CCS group was significantly higher than that in the blank CCS group.”
Quote in the paperSubstantial claim- Rests on an assumption: IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
- Findingown data
NAg-CCS releases NAg constantly for two weeks.
“the results showed that it could release NAg constantly for two weeks”
- Also stated in: § 3.1 Construction and characterization of NAg-CCS · plain
“The NAg-CCS group showed a slow release of NAg within two weeks”
Quote in the paperSubstantial claim - Also stated in: § 3.1 Construction and characterization of NAg-CCS · plain
- Findingown data
In the miniature pig wound model, from postoperative Day 14 onward, the NAg-CCS group had significantly smaller wounds than the blank CCS group.
“On postoperative Day 14 onward, a significant difference in the rate of wound healing was found between the two groups: the NAg-CCS group had significantly smaller wounds than the blank CCS group.”
Quote in the paperSubstantial claim - Findingown data
In the rat subcutaneous implantation, qRT-PCR showed IL-10 expression in the NAg-CCS group on both days was significantly higher than in the blank CCS group.
“the expression of IL-10 in the NAg-CCS group on both days after scaffold implantation was significantly higher than that of the blank CCS group”
Quote in the paperSubstantial claim - Findingown data
In the miniature pig wound model, both groups showed numerous inflammatory cells infiltrating the scaffold at an early stage.
“Both groups showed numerous inflammatory cells, such as monocytes, which infiltrated the scaffold at an early stage.”
Quote in the paperNot a substantial claim - Findingown data
M1 macrophages in the wound tissues of the NAg-CCS group were significantly lower than in the blank CCS group.
“The results showed that M1 macrophages in the wound tissues of the NAg-CCS group were significantly lower than that of the blank CCS group”
Quote in the paperSubstantial claim - Findingown data
CD163 mRNA expression in the wounds of the NAg-CCS group was significantly higher than in the blank CCS group.
“The results showed that the expression of CD163 in the wounds of the NAg-CCS group was significantly higher”
Quote in the paperSubstantial claim - Findingown data
In the miniature pig wound model, the NAg-CCS group had stratified epithelial cells on postoperative Day 21.
“Additionally, the NAg-CCS group had stratified epithelial cells on postoperative Day 21.”
Quote in the paperSubstantial claim - Findingown data
In the miniature pig wound model, a single layer of epidermal cells formed on the wound surface in the NAg-CCS group.
“A single layer of epidermal cells had formed on the wound surface in the NAg-CCS group.”
Quote in the paperSubstantial claim - Findingown data
Protein level of collagen III in the NAg-CCS group was reduced at most time points except for Day 28 compared to the blank CCS group.
“while collagen III was reduced at most time points except for Day 28 (Figs.5c and 5d).”
Quote in the paperSubstantial claim - Findingown data
M2 macrophage aggravation in the NAg-CCS group was more abundant than in the blank CCS group.
“while M2 macrophage aggravation in the NAg-CCS group was more abundant.”
Quote in the paperSubstantial claim - Findingown data
CD68 mRNA expression in the wounds of the NAg-CCS group was significantly lower than in the blank CCS group.
“but the expression of CD68 significantly lower, than that in the blank CCS group (Fig. 6a).”
Quote in the paperSubstantial claim - Findingown data
In the wound healing study, M1 macrophage activation and inflammatory-related proteins (iNOS, IL-6, IFN-γ) were inhibited by NAg.
“In the wound healing study, M1 macrophage activation and inflammatory-related proteins (inducible nitric oxide synthase (iNOS), IL-6, and interferon-γ (IFN-γ)) were inhibited by NAg.”
Quote in the paperSubstantial claim- Rests on an assumption: IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
- Findingown data
CD163 protein expression was dominant in the NAg-CCS group only during the first two weeks.
“western blotting revealed that CD163 expression was dominant in the NAg-CCS group only during the first two weeks”
Quote in the paperNot a substantial claim - Findingown data
In the miniature pig wound model, the blank CCS group had uneven collagen distribution, showing as clumps or bundles in the later stage.
“Evaluation of collagen regeneration showed that the blank CCS group had an uneven collagen distribution, showing as clumps or bundles in the later stage”
Quote in the paperSubstantial claim - Findingown data
Overall transcript levels of collagen types I and III increased with time in the wounds.
“The results of qRT-PCR (Fig. 5b) showed that the overall transcript levels of collagen types I and III increased with time.”
Quote in the paperNot a substantial claim - Findingown data
Western blotting confirmed differences in proinflammatory and anti-inflammatory cytokine expression between the NAg-CCS and blank CCS groups.
“Similar findings from western blotting confirmed the differences in proinflammatory and anti-inflammatory cytokine expression (Figs. 6e and 6f).”
Quote in the paperSubstantial claim - Findingown data
Wounds repaired by scaffolds without NAg had more M1 macrophage aggregation in the early and middle stages.
“Our results showed that wounds repaired by scaffolds without NAg had more M1 macrophage aggregation in the early and middle stages.”
Quote in the paperSubstantial claim - Findingown data
CD68 protein expression was always higher in the blank CCS group.
“while CD68 expression was always higher in the blank CCS group (Figs.6b and 6c).”
Quote in the paperSubstantial claim - Findingown data
mRNA expression levels of collagen types I and III at different postoperative time points were lower in the NAg-CCS group than in the blank CCS group.
“The mRNA expression levels of collagen types I and III at different postoperative time points in the NAg-CCS group were lower than those in the blank CCS group.”
Quote in the paperSubstantial claim - Findingown data
Protein level of collagen I in the NAg-CCS group was always lower than that in the blank CCS group at different postoperative time points.
“The results of western blotting showed that the protein level of collagen I in the NAg-CCS group was always lower than that in the blank CCS group at different postoperative time points”
Quote in the paperSubstantial claim - Findingown data
In early and intermediate stages of wound tissue repair (postoperative Days 7, 10, 14, and 21), mRNA expression of anti-inflammatory cytokines arginase-I, MHC-II, and FIZZ-1 was significantly increased in the NAg-CCS group.
“while that of anti-inflammatory cytokines, including arginase-I, MHC-II, and FIZZ-1, was significantly increased in the NAg-CCS group (Fig. 6d).”
Quote in the paperSubstantial claim - Findingown data
In early and intermediate stages of wound tissue repair (postoperative Days 7, 10, 14, and 21), mRNA expression of proinflammatory cytokines iNOS, IL-6, and IFN-γ was significantly reduced in the NAg-CCS group.
“in the early and intermediate stages of wound tissue repair (postoperative Days 7, 10, 14, and 21), the mRNA expression of proinflammatory cytokines iNOS, IL-6, and IFN-γ of the NAg-CCS group was significantly reduced”
Quote in the paperSubstantial claim - Findingown data
Masson's trichrome staining showed that the contents of collagen types I and III in the dermal tissues of the NAg-CCS group were lower than those in the blank-CCS group.
“Results showed that the contents of collagen types I and III in the dermal tissues of the NAg-CCS group were lower than those in the blank-CCS group (Fig. 6b).”
Quote in the paperSubstantial claim - Interpretationown data
NAg suppresses the foreign body reaction.
“thereby suppressing the foreign body reaction”
Quote in the paperSubstantial claim - Interpretationown data
NAg can ameliorate the inflammatory microenvironment.
“and ameliorate the inflammatory microenvironment”
Quote in the paperSubstantial claim - Interpretationown data
NAg can activate macrophage conversion.
“NAg can activate macrophage conversion”
Quote in the paperSubstantial claim - Interpretationown data
NAg-CCS was able to induce macrophage differentiation.
“and induce macrophage differentiation.”
Quote in the paperSubstantial claim - Interpretationown data
NAg-CCS was able to reduce inflammation.
“and was able to reduce inflammation”
Quote in the paperSubstantial claim - Interpretationown data
NAg-CCS had good biocompatibility.
“Our research demonstrated that NAg-CCS had good biocompatibility”
Quote in the paperSubstantial claim - Interpretationreasoning
An orderly transition from the inflammatory phase to the recovery phase is critical for extending the retention of implanted scaffolds.
“Therefore, an orderly transition from the inflammatory phase to the recovery phase is critical for extending the retention of implanted scaffolds.”
Quote in the paperSubstantial claim - Interpretationreasoning
NAg induces regeneration and in situ repair of skin wounds.
“and inducing regeneration and in situ repair of skin wounds.”
Quote in the paperSubstantial claim - Interpretationreasoning
NAg facilitates the deposition of ECM.
“thereby facilitating the deposition of ECM”
Quote in the paperNot a substantial claim - Interpretationown data
NAg accelerates transition of the repair process from the inflammatory phase to the proliferation phase by regulating M2 macrophage conversion.
“Also, NAg accelerates transition of the repair process from the inflammatory phase to the proliferation phase by regulating M2 macrophage conversion”
Quote in the paperSubstantial claim - Interpretationreasoning
NAg promotes high-quality wound healing.
“and promoting high-quality wound healing.”
Quote in the paperSubstantial claim - Interpretationown data
NAg-CCS successfully alleviates inflammation around implants.
“NAg-CCS successfully alleviates foreign body reactions and inflammation around implants”
Quote in the paperSubstantial claim - Interpretationown data
NAg-CCS successfully alleviates foreign body reactions around implants.
“NAg-CCS successfully alleviates foreign body reactions and inflammation around implants”
Quote in the paperSubstantial claim - Interpretationown data
NAg-CCS promotes wound repair by suppressing M1 macrophage activation and inflammatory cytokine secretion.
“and promotes wound repair by suppressing M1 macrophage activation and inflammatory cytokine secretion.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 9
- May combine two claims. 29
Classified as probably not a substantial claim. May combine two claims.
PremisecitationAs foreign bodies, successful implantations of tissue engineering products should overcome two obstacles: infection and foreign body reactions.
“However, as foreign bodies, successful implantations of these products should overcome two obstacles: infection and foreign body reactions”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Weng et al., 2020 source
The Introduction (page unavailable) says skin-replacement biomaterials must protect wounds from infection, supporting one of the two stated obstacles. The passages on scaffold requirements and challenges do not identify foreign body reactions as an obstacle to implantation. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationiNOS is an intermediate metabolite of activated M1 macrophages involved in antibacterial-related biological processes.
“iNOS is an intermediate metabolite of activated M1 macrophages involved in antibacterial-related biological processes (Orecchioni et al., 2019;Paul et al., 2019).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Orecchioni et al., 2019 source
The “In vivo M1 and in vitro Classically Activated Mφ Common Pathways” section says iNOS signaling is enriched and is a main bacterial-killing pathway in these macrophages. The “In vivo and in vitro M1 Signatures” section identifies iNos (Nos2) as a gene, not an intermediate metabolite; that characterization is unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Paul et al., 2019 source
The Introduction (page not supplied) says M1 macrophages produce iNOS, and the Results (page not supplied) use iNOS as a marker of M1 macrophages. The paper identifies iNOS as inducible nitric oxide synthase, not an intermediate metabolite, and the cited passages concern anti-tumor immunity rather than antibacterial processes. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn the absence of NAg, long-term abnormal inflammation of the wound tissue may occur resulting in granulomas, infection, or necrosis, eventually leading to the failure of tissue repair.
“Hence, in the absence of NAg, long-term abnormal inflammation of the wound tissue may occur resulting in granulomas, infection, or necrosis, eventually leading to the failure of tissue repair (Chu et al., 2020;Witherel et al., 2021).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Chu et al., 2020 source
- cites Witherel et al., 2021 source
The Introduction (page not provided) says that fibrosis can occur when wound healing fails to resolve, supporting the general link between unresolved healing and pathological tissue changes. It does not address the absence of NAg or say that prolonged inflammation causes granulomas, infection, or necrosis leading to failed repair. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWound healing of burns and trauma is compromised by various unfavorable factors, the most common of which are wound infection and an abnormal inflammatory response.
“Wound healing of burns and trauma is compromised by various unfavorable factors, the most common of which are wound infection and an abnormal inflammatory response”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Shi et al., 2020 source
The Burns section says infection can worsen superficial and partial-thickness burns, and that increasing exudate during the inflammatory phase can delay healing. It does not identify an abnormal inflammatory response as a cause or establish infection and that response as the most common factors compromising healing of burns and trauma. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites Yang et al., 2021 source
The Introduction says excessive inflammation and bacterial colonization can prolong healing in diabetic wounds; the Anti-inflammation evaluation likewise calls increased inflammation a major cause of prolonged wound closure in diabetic patients. These passages support the general concern, but they do not establish it specifically for burns and trauma or show that infection and abnormal inflammation are the most common unfavorable factors in those wounds. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationM1 and M2 macrophages play coordinating roles in the wound healing process by secreting cytokines such as IL-6, TGF-β, TNF-α, and IL-8 to mobilize peripheral or systemic monocytes and lymphocytes to gather around the wound surface.
“M1 and M2 macrophages also play coordinating roles in the wound healing process by secreting cytokines, such as IL-6, transforming growth factor-β (TGF-β), tumor necrosis factor-α (TNF-α), and IL-8, to mobilize peripheral or systemic monocytes and lymphocytes to gather around the wound surface (Snyder et al., 2016;Wynn and Vannella, 2016).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Snyder et al., 2016 source
- cites Wynn and Vannella, 2016 source
The Introduction (page unavailable) says macrophages of different phenotypes regulate stages of wound repair and produce inflammatory mediators; it also identifies TGF-β1 as a product of wound-healing macrophages. The Tissue Regeneration section (page unavailable) describes TNF-α-producing inflammatory macrophages, but says CCL2 from neighboring hair follicles recruits them. These passages do not support the specific claim that macrophage-secreted IL-6, TGF-β, TNF-α, and IL-8 mobilize monocytes and lymphocytes to the wound surface. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationActivation of M2 macrophages at an earlier stage led to faster matrix synthesis and deposition around the implant, reduced the foreign body reaction caused by inflammatory activation, and enabled the healing process to shift from the inflammatory phase to the proliferative phase more quickly, achieving complete wound healing and reducing scar formation.
“Activation of M2 macrophages at an earlier stage led to faster matrix synthesis and deposition around the implant (Li and Cui, 2021;Furtado et al., 2022), reduced the foreign body reaction caused by inflammatory activation, and enabled the healing process to shift from the inflammatory phase to the proliferative phase more quickly, achieving complete wound healing and reducing scar formation.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Li and Cui, 2021 source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites Furtado et al., 2022 source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIFN-γ and TNF-α induce activation of M1 macrophages to trigger a respiratory burst, release reactive oxygen species, secrete TNF-α and IL-12, induce iNOS, and upregulate expression of programmed death-ligand 1 (PD-L1).
“IFN-γ and TNF-α induce activation of Ml macrophages to trigger a respiratory burst, release reactive oxygen species, secrete TNF-α and IL-12, induce iNOS, and upregulate expression of programmed death-ligand 1 (PD-L1) (Jain and Vogel, 2018;Tan et al., 2019).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Jain and Vogel, 2018 source
The Methods (Macrophage activation; page not provided) use LPS, not IFN-γ and TNF-α, to induce M1 activation. The sections on late pro-inflammatory gene expression and cytokine secretion report iNOS expression and secretion of TNF-α and IL-12 after LPS stimulation. Our copy does not establish the claimed respiratory burst, reactive oxygen species release, or PD-L1 upregulation. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Tan et al., 2019 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationM2 macrophages are induced by IL-4 and IL-13 to upregulate IL-10 and FIZZ-1 and secrete less IL-12 and nitric oxide, weakening the phagocytosis of pathogenic microorganisms.
“M2 macrophages are induced by IL-4 and IL-13 to upregulate IL-10 and FIZZ-1 and secrete less IL-12 and nitric oxide, weakening the phagocytosis of pathogenic microorganisms (Locati et al., 2020;Yunna et al., 2020;Witherel et al., 2021).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites Locati et al., 2020 source
The sections on macrophage plasticity and adaptation to the tumor microenvironment (pages unavailable) identify IL-4 and IL-13 as drivers of M2 or M2-like activation. The post-transcriptional-control section reports reduced iNOS and IL-12 alongside M2 markers in a specific microRNA-related context. Our copy does not establish the claimed IL-10 and FIZZ-1 upregulation or that these changes weaken phagocytosis of pathogenic microorganisms. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites Yunna et al., 2020 source
- cites Witherel et al., 2021 source
The Results (Preparation of hybrid macrophage phenotypes) and Discussion say that IL-4 and IL-13 promote M2 polarization. The paper does not report the claimed increase in IL-10 and FIZZ-1, decrease in IL-12 and nitric oxide, or weakened phagocytosis of pathogens. The Discussion instead distinguishes IL-10-stimulated M2c macrophages from the IL-4/IL-13-stimulated M2a phenotype studied here. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
Interpretationown dataNAg-CCS inhibited the inflammatory response to foreign bodies and promoted high-quality tissue repair.
“These results indicated that NAg-CCS inhibited the inflammatory response to foreign bodies and promoted high-quality tissue repair (You et al., 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites You et al., 2017 source
May combine two claims.
Findingown dataNAg was evenly distributed and tightly combined with the collagen in the NAg-CCS.
“The NAg was evenly distributed and tightly combined with the collagen”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the rat subcutaneous implantation, the NAg-CCS group rarely developed a foreign body reaction, while the blank-CCS group showed granulomas or necrosis.
“The NAg-CCS group rarely developed a foreign body reaction, while the blank-CCS group showed granulomas or necrosis in the subcutaneous grafting experiment.”
- Also stated in: § 3.2 Subcutaneous implantation of scaffolds in rats · plain
“In the NAg-CCS group, no foreign body reaction was observed around the scaffolds”
Quote in the paperSubstantial claim- Rests on an assumption: The blank CCS and NAg-CCS differ only in the presence of NAg, so observed differences are attributable to NAg.
- Also stated in: § 3.2 Subcutaneous implantation of scaffolds in rats · plain
May combine two claims.
Findingown dataIn the miniature pig wound model, wound healing of the NAg-CCS group was faster and better than that of the blank CCS group.
“They show that the wound healing of the NAg-CCS group was faster and better than that of the blank CCS group”
- Also stated in: § 3.4 Wound repair experiment in miniature pigs · plain
“Calculation of the wound area at different time points after implantation confirmed that the wound healing rate of the NAg-CCS group was significantly faster than that of the blank CCS group”
Quote in the paperSubstantial claim- Rests on an assumption: The blank CCS and NAg-CCS differ only in the presence of NAg, so observed differences are attributable to NAg.
- Rests on an assumption: The rat subcutaneous implantation model and miniature pig wound model are adequate to predict the effects of NAg-CCS on foreign body reaction and wound healing in humans.
- Also stated in: § 3.4 Wound repair experiment in miniature pigs · plain
May combine two claims.
Findingown dataIn the rat subcutaneous implantation, the NAg-CCS group had fewer multinucleated giant cells and more orderly tissue growth than the blank CCS group.
“The NAg-CCS group had fewer multinucleated giant cells and the tissue grew in a more orderly manner”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNAg-CCS has a porous, sponge-like structure.
“NAg-CCS has a porous structure”
- Also stated in: § 3.1 Construction and characterization of NAg-CCS · plain
“They were slightly yellow, with hollow and sponge-like structures inside the scaffold.”
Quote in the paperNot a substantial claim- Also stated in: § 3.1 Construction and characterization of NAg-CCS · plain
May combine two claims.
Findingown dataThe blank CCS with a mixture of NAg released 50% of NAg on Day 2, while no sudden release was observed in the NAg-CCS group.
“The release study revealed that the blank CCS with a mixture of NAg released 50% of NAg on Day 2, while no sudden release was observed in the NAg-CCS group”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe cumulative release of NAg from NAg-CCS was (80.45±1.70)%, slightly lower than that of the blank CCS group ((90.78±5.21)%).
“the cumulative release of NAg was (80.45±1.70)%, which was slightly lower than that of the blank CCS group ((90.78±5.21)%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, on postoperative Day 7, the NAg-CCS group wound was red and moist, while the blank CCS group wound failed to combine tightly with little substantial neovascularization.
“On postoperative Day 7, the wound of the NAg-CCS group was red and moist, while the wound and blank CCS failed to combine tightly in the blank CCS group, with little substantial neovascularization on the wound base.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, in the NAg-CCS group, the scaffold structure was degraded and there was flocculent secretion of new collagen at the base on postoperative Day 7.
“In the NAg-CCS group, the scaffold structure was degraded, and there was a flocculent secretion of new collagen at the base on postoperative Day 7.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, on postoperative Day 14, inflammation in the blank-CCS group was still pronounced without evident epithelialization, while inflammatory cell infiltration in the NAg-CCS group was significantly reduced compared with Day 7.
“On postoperative Day 14, inflammation in the blank-CCS group was still pronounced, without showing evident epithelialization; in contrast, the infiltration of inflammatory cells in the NAg-CCS group was significantly reduced compared with that on postoperative Day 7.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, HE staining on Day 7 showed the NAg-CCS scaffolds were replaced by new granulation tissues, while residual scaffolds in the blank CCS group were distinguishable with hyperemia, loose tissues, and gaps.
“HE staining (Fig. 4d) showed that on Day 7, the scaffolds of the NAg-CCS group had been replaced by new granulation tissues, while the residual scaffolds in the blank CCS group were easily distinguishable from the surrounding tissues, showing hyperemia, loose tissues, and gaps.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, by the third week after implantation, collagen deposition in the NAg-CCS group was reduced, while the blank CCS group still had numerous collagen depositions showing as globular forms.
“By the third week after implantation, the collagen deposition of the NAg-CCS group was reduced, while the blank CCS group still had numerous collagen depositions, showing as globular forms.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, on postoperative Day 14, newly formed collagen in the NAg-CCS group was staggered, and the inflammatory response was gradually reducing.
“In contrast, the newly formed collagen in the NAg-CCS group was staggered, and the inflammatory response of the NAg-CCS group was gradually reducing.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, on postoperative Day 14, the blank CCS group still had degraded collagen particles and newly formed collagen was disordered.
“On postoperative Day 14, the blank CCS group still had degraded collagen particles, and the newly formed collagen was disordered.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, on postoperative Day 28, collagen in the blank CCS group was distributed unidirectionally in bundles, while collagen in the NAg-CCS group was distributed in a staggered pattern.
“On postoperative Day 28, unidirectional distribution of collagen in bundles was observed in the blank CCS group, while the collagen in the NAg-CCS group was distributed in a staggered pattern.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, on postoperative Day 60, skin repaired by NAg-CCS had an epidermis and dermis with mature and complete skin appendages, while the blank CCS group had a disordered skin tissue structure.
“On postoperative Day 60, the skin repaired by the NAg-CCS had an epidermis and dermis, with mature and complete skin appendages; in contrast, the blank CCS group had a disordered skin tissue structure.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the wound healing study, M2 macrophage activation and proteins (arginase-1, MHC-II, FIZZ-1) were promoted by NAg.
“In contrast, M2 macrophage activation and proinflammatory proteins (arginase-1, major histocompatibility complex-II (MHC-II), and found in inflammatory zone-1 (FIZZ-1)) were promoted”
Quote in the paperSubstantial claim- Rests on an assumption: IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
May combine two claims.
Findingown dataIn the miniature pig wound model, in the early stage, the regenerated dermis of both groups was thin; the blank CCS group still had a visible undegraded scaffold surrounded by many inflammatory cells and blood cells.
“In the early stage, the regenerated dermis of the two groups was thin; the blank CCS group still had a visible undegraded scaffold, which was blue-gray and was surrounded by many inflammatory cells and blood cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the miniature pig wound model, collagen regeneration of the NAg-CCS group was stable and orderly, with uniform collagen distribution.
“The collagen regeneration of the NAg-CCS group was stable and orderly, and collagen distribution was uniform”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe inflammatory response of the NAg-CCS group was gradually alleviated, and the newly formed collagen in the NAg-CCS group was staggered, almost resembling normal skin on postoperative Days 21 and 28.
“Additionally, the inflammatory response of the NAg-CCS group was gradually alleviated, and the newly formed collagen in the NAg-CCS group was staggered, almost resembling normal skin on postoperative Days 21 and 28.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDermal scaffolds containing NAg suppressed the foreign body reaction by regulating macrophages and the expression of inflammatory cytokines, thereby promoting wound healing.
“In conclusion, dermal scaffolds containing NAg suppressed the foreign body reaction by regulating macrophages and the expression of inflammatory cytokines, thereby promoting wound healing.”
Quote in the paperSubstantial claim- Rests on an assumption: NAg is released from NAg-CCS in vivo in a manner similar to the in vitro release profile.
- Rests on an assumption: The blank CCS and NAg-CCS differ only in the presence of NAg, so observed differences are attributable to NAg.
- Rests on an assumption: IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
- Rests on an assumption: In wound repair, M1 and M2 macrophages are sequentially activated, with M1 early and M2 in the middle stage.
- Rests on an assumption: The rat subcutaneous implantation model and miniature pig wound model are adequate to predict the effects of NAg-CCS on foreign body reaction and wound healing in humans.
May combine two claims.
InterpretationreasoningThe promotion of M2 macrophage activation and proteins was responsible for suppressing foreign body responses and accelerating wound healing.
“and this was responsible for suppressing the foreign body responses and accelerating wound healing.”
Quote in the paperSubstantial claim- Rests on an assumption: IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
- Rests on an assumption: In wound repair, M1 and M2 macrophages are sequentially activated, with M1 early and M2 in the middle stage.
May combine two claims.
InterpretationreasoningNAg ameliorated the foreign body reaction after scaffold implantation and reduced the infiltration of giant cells and inflammatory cells around the scaffolds in the early stage.
“This indicated that NAg ameliorated the foreign body reaction after scaffold implantation and reduced the infiltration of giant cells and inflammatory cells around the scaffolds in the early stage.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationInflammation plays a dominant role in necrosis elimination, pathogen suppression, and regulation of the immune microenvironment.
“Inflammation, as an important component present throughout the whole period of wound repair, plays a dominant role in necrosis elimination, pathogen suppression, and regulation of the immune microenvironment”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenExperiments were approved and supervised by the Animal Care and Ethical Committee of the Second Affiliated Hospital of Zhejiang University (No. 2020-720).
“Experiments were approved and supervised by the Animal Care and Ethical Committee of the Second Affiliated Hospital of Zhejiang University (No. 2020-720).”
Quote in the paperNot a substantial claim
The paper relies on this without support.
NAg is released from NAg-CCS in vivo in a manner similar to the in vitro release profile.
“The NAg-CCS group showed a slow release of NAg within two weeks”
The paper relies on this without support.
The blank CCS and NAg-CCS differ only in the presence of NAg, so observed differences are attributable to NAg.
“followed by subcutaneous implantation of an NAg-CCS (one on one side and the blank CCS on the other side).”
The paper relies on this without support.
IL-6 and IL-10 are valid markers of M1 and M2 macrophages in this model.
“the number of IL-6-positive cells (M1 macrophages) on Days 3 and 7 after scaffold implantation in the NAg-CCS group was much lower than that in the blank CCS group”
“the number of IL-10-positive cells (M2 macrophages) on Day 3 after scaffold implantation in the NAg-CCS group was not significantly different from that of the blank CCS group”
The paper relies on this without support.
In wound repair, M1 and M2 macrophages are sequentially activated, with M1 early and M2 in the middle stage.
“In the process of wound repair, two types of macrophages are sequentially activated.As a scavenger, M1 macrophages participate in antiinfection and the formation of foreign-body giant cells at the early stage, whereas M2 macrophages are involved mainly in the middle stage of wound repair.”
The paper relies on this without support.
The rat subcutaneous implantation model and miniature pig wound model are adequate to predict the effects of NAg-CCS on foreign body reaction and wound healing in humans.
“The NAg-CCS was implanted on the back of rats to evaluate the effects on foreign body reactions.”
“Miniature pigs were used to assess the effects of NAg on skin wound healing.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
A collagen finding cites a macrophage-marker panel
MinorThe discussion cites Fig. 6b for collagen I and III content, but the caption identifies that panel as western blots of CD163 and CD68.
“Results showed that the contents of collagen types I and III in the dermal tissues of the NAg-CCS group were lower than those in the blank-CCS group (Fig. 6b).”
“(b) Representative images showing results for western blotting of CD163 and CD68.”
The same markers are classified as both pro- and anti-inflammatory
MinorThe abstract calls arginase-1, MHC-II, and FIZZ-1 proinflammatory, whereas the results classify the same three markers as anti-inflammatory.
“In contrast, M2 macrophage activation and proinflammatory proteins (arginase-1, major histocompatibility complex-II (MHC-II), and found in inflammatory zone-1 (FIZZ-1)) were promoted”
“while that of anti-inflammatory cytokines, including arginase-I, MHC-II, and FIZZ-1, was significantly increased in the NAg-CCS group (Fig. 6d).”
The control scaffold's 50% silver release is dated differently
MinorThe results place the control's approximately 50% release on Day 2, while the Fig. 1 caption places the sudden release on Day 1.
“The release study revealed that the blank CCS with a mixture of NAg released 50% of NAg on Day 2”
“the mixed NAg in blank CCS exhibited a sudden release on Day 1, while a slow and sustained release of NAg was observed in the NAg-CCS group ((50.55±3.29)% vs. (10.34±1.88)%,*** P<0.001).”
Cites
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138 · cited 4× · see citing works
“Besides, overactive M1 macrophages can also activate M2 macrophages inten‐ sively, resulting in a subsequent proliferation of fibrous tissues surrounding the scaffold and aggravating the formation of foreign body granulomas (Anderson et al., 2008; Witherel et al., 2021).”
BackgroundInfluentialMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481 · see citing works
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890 · see citing works
Yunna, C., Mengru, H., Lei, W., & Weidong, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173090 · Cited by 2,454 · cited 1× · see citing works
“M2 macrophages are induced by IL-4 and IL-13 to upregu‐ late IL-10 and FIZZ-1 and secrete less IL-12 and nitric oxide, weakening the phagocytosis of pathogenic microorganisms (Locati et al., 2020; Yunna et al., 2020; Witherel et al., 2021).”
BackgroundDiversity, Mechanisms, and Significance of Macrophage Plasticity
Locati, M., Curtale, G., & Mantovani, A. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012718 · Cited by 2,199 · see citing works
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063 · see citing works
Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing
Hesketh, M., Sahin, K. B., West, Z. E., & Murray, R. Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071545 · Cited by 852 · see citing works
Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials
Sheikh, Z., Brooks, P., Barzilay, O., Fine, N., & Glogauer, M. (2015) · Materials · doi:10.3390/ma8095269 · Cited by 701 · see citing works
Mechanisms of Organ Injury and Repair by Macrophages
Vannella, K. M., & Wynn, T. A. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034356 · Cited by 656 · see citing works
Exosome‐Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing
Kim, H., Wang, S. Y., Kwak, G., Yang, Y., Kwon, I. C., & Kim, S. H. (2019) · Advanced Science · doi:10.1002/advs.201900513 · Cited by 542 · see citing works
Self-citationSelection of Appropriate Wound Dressing for Various Wounds
Shi, C., Wang, C., Liu, H., Li, Q., Li, R., Zhang, Y., Liu, Y., Shao, Y., & Wang, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00182 · Cited by 522 · see citing works
You, C., Han, C., Wang, X., Zheng, Y., Li, Q., Hu, X., & Sun, H. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1792-8 · Cited by 447 · see citing works
Self-citationYou, C., Li, Q., Wang, X., Wu, P., Ho, J. K., Jin, R., Zhang, L., Shao, H., & Han, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-10481-0 · Cited by 304 · see citing works
Self-citationSpatial confinement downsizes the inflammatory response of macrophages
Jain, N., & Vogel, V. (2018) · Nature Materials · doi:10.1038/s41563-018-0190-6 · Cited by 271 · see citing works
Macrophages: A review of their role in wound healing and their therapeutic use
Snyder, R. J., Lantis, J., Kirsner, R. S., Shah, V., Molyneaux, M., & Carter, M. J. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12444 · Cited by 245 · see citing works
Regulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages
Witherel, C. E., Sao, K., Brisson, B. K., Han, B., Volk, S. W., Petrie, R. J., Han, L., & Spiller, K. L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120667 · Cited by 212 · see citing works
Development of fish collagen in tissue regeneration and drug delivery
Furtado, M., Chen, L., Chen, Z., Chen, A., & Cui, W. (2022) · Engineered Regeneration · doi:10.1016/j.engreg.2022.05.002 · Cited by 199 · see citing works
Dermal fillers: pathophysiology, prevention and treatment of complications
Chiang, Y. Z., Pierone, G., & Al‐Niaimi, F. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13977 · Cited by 192 · see citing works
Yang, Y., Zhao, X., Yu, J., Chen, X., Wang, R., Zhang, M., Zhang, Q., Zhang, Y., Wang, S., & Cheng, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.007 · Cited by 180 · see citing works
Self-citationRegeneration of skin appendages and nerves: current status and further challenges
Weng, T., Wu, P., Zhang, W., Zheng, Y., Li, Q., Jin, R., Chen, H., You, C., Guo, S., Han, C., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02248-5 · Cited by 158 · see citing works
Self-citationPaul, S., Chhatar, S., Mishra, A., & Lal, G. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0697-7 · Cited by 150 · see citing works
Modulation of foreign body reaction and macrophage phenotypes concerning microenvironment
Chu, C., Liu, L., Rung, S., Wang, Y., Ma, Y., Hu, C., Zhao, X., Man, Y., & Qu, Y. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36798 · Cited by 131 · see citing works
Tan, R.-Z., Liu, J., Zhang, Y.-Y., Wang, H.-L., Li, J.-C., Liu, Y.-H., Zhong, X., Zhang, Y.-W., Yan, Y., Lan, H.-Y., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2018.09.210 · Cited by 122 · see citing works
Alginate-based composite sponge containing silver nanoparticles synthesized in situ
Seo, S. Y., Lee, G. H., Lee, S. G., Jung, S. Y., Lim, J. O., & Choi, J. H. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.05.002 · Cited by 103 · see citing works
Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound
Wicks, K., Torbica, T., & Mace, K. A. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.006 · Cited by 93 · see citing works
Huang, Y.-J., Hung, K.-C., Hung, H.-S., & Hsu, S.-H. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04718 · Cited by 89 · see citing works
Biomimetic immunomodulation strategies for effective tissue repair and restoration
Villarreal-Leal, R. A., Healey, G. D., & Corradetti, B. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113913 · Cited by 86 · see citing works
OʼShea, T. M., Wollenberg, A. L., Kim, J. H., Ao, Y., Deming, T. J., & Sofroniew, M. V. (2020) · Nature Communications · doi:10.1038/s41467-020-19906-3 · Cited by 70 · see citing works
3D bioprinting of cell-laden constructs for regenerative medicine
Li, C., & Cui, W. (2021) · Engineered Regeneration · doi:10.1016/j.engreg.2021.11.005 · Cited by 70 · see citing works
Metal-organic framework (MOF)-based biomaterials in bone tissue engineering
Liu, C., Xu, X., Cui, W., & Zhang, H. (2021) · Engineered Regeneration · doi:10.1016/j.engreg.2021.09.001 · Cited by 59 · see citing works
Shi, K., Qiu, X., Zheng, W., Yan, D., & Peng, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.152 · Cited by 56 · see citing works
Anderson, J. M., & Jiang, S. (2017) · The Immune Response to Implanted Materials and Devices · doi:10.1007/978-3-319-45433-7_2 · Cited by 55 · see citing works
Biocompatibility of a Marine Collagen-Based Scaffold In Vitro and In Vivo
Benayahu, D., Pomeraniec, L., Shemesh, S., Heller, S., Rosenthal, Y., Rath-Wolfson, L., & Benayahu, Y. (2020) · Marine Drugs · doi:10.3390/md18080420 · Cited by 42 · cited 1× · see citing works
“As a result, uncontrolled infection or inflammation at the early stage of implant‑ ation may lead to foreign body reactions and granuloma formation, which suppresses the physiological process of skin wound healing (Huang et al., 2018; Benayahu et al., 2020).”
BackgroundChronic Venous Insufficiency and the Therapeutic Effects of Daflon 500 mg
Bergan, J. J. (2005) · Angiology · doi:10.1177/00033197050560i104 · Cited by 37 · see citing works
M2 Macrophages Promote Collagen Expression and Synthesis in Laryngotracheal Stenosis Fibroblasts
Motz, K., Lina, I. A., Murphy, M. K., Drake, V. E., Davis, R. J., Tsai, H., Feeley, M., Yin, L. X., Ding, D., & Hillel, A. T. (2020) · The Laryngoscope · doi:10.1002/lary.28980 · Cited by 36 · see citing works
Alsaleh, N. B., Minarchick, V. C., Mendoza, R. P., Sharma, B., Podila, R., & Brown, J. M. (2019) · Journal of Immunotoxicology · doi:10.1080/1547691x.2019.1588928 · Cited by 35 · see citing works
Adipocytes and macrophages secretomes coregulate catecholamine-synthesizing enzymes
Gomes, A., Leite, F., & Ribeiro, L. V. P. T. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.52219 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Targeting Macrophage Polarization for Reinstating Homeostasis following Tissue Damage
Du, Q., Dickinson, A., Nakuleswaran, P., Maghami, S., Alagoda, S., Hook, A. L., & Ghaemmaghami, A. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137278 · Cited by 49 · see citing works
“You et al. carried out several studies and demonstrated the use of nanosilver (NAg) in collagen-chitosan scaffolds (CCS) for orchestrating the polarization of macrophages from the M1 inflammatory state to the M2 pro-healing state [347–349].”
BackgroundCeria nanoparticles: biomedical applications and toxicity
Fu, X., Li, P., Chen, X., Ma, Y., Wang, R., Ji, W., Gu, J., Sheng, B., Wang, Y., & Zhang, Z. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300854 · Cited by 49 · see citing works
Approaches to Control and Monitor Protease Levels in Chronic Wounds
Kolahreez, D., Ghasemi‐Mobarakeh, L., Liebner, F. W., Alihosseini, F., Quartinello, F., Guebitz, G. M., & Ribitsch, D. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300396 · Cited by 24 · see citing works
Li, X., Pang, L., Duan, J., Huang, N., Chen, X., Huang, W., Liu, Y., Fu, C., Zhang, C., Tu, H., et al. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.12.019 · Cited by 20 · see citing works
Abu-Baker, A., Țigăran, A.-E., Peligrad, T., Ion, D.-E., Gheoca-Mutu, D.-E., Avino, A., Hariga, C.-S., Moraru, O. E., Răducu, L., & Jecan, C. R. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020206 · Cited by 18 · see citing works
“…glucose, demonstrating that these macrophages are polarizing on a continuous spectrum toward M2-macrophages, as an increased expression of glucose transporters (primarily GLUT1) on the membrane and higher rates of glucose consumption have been associated with pro-inflammatory M1 macrophages [40].”
BackgroundZeng, Y., Xie, X., Gao, Y., et al. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105952 · Cited by 13 · see citing works
Self-citationSergeevichev, D., Dorovskikh, S. I., Vikulova, E. S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021100 · Cited by 13 · see citing works
Liu, J., Chen, B., & Yang, I. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115191 · Cited by 5 · see citing works
Zhang, C., Fu, Z., Liu, Q., Guo, X., Zhao, L., Song, W. D., Kong, Y., Du, J., Su, Y., Yu, B., et al. (2025) · Biofabrication · doi:10.1088/1758-5090/add49f · Cited by 6 · see citing works
Hossen, M. R., Alam, M. S., Hasan, S., & Hossain, M. I. (2025) · Biomedical Engineering Advances · doi:10.1016/j.bea.2025.100199 · Cited by 3 · see citing works
Ma, Q., Yin, A., Wan, X., Sun, B., Wang, H., El-Newehy, M. H., Abdulhameed, M. M., Mo, X., Wu, J., & Tu, T. (2025) · Biomedical Materials · doi:10.1088/1748-605x/adae48 · Cited by 3 · see citing works
Zarouki, M. A., Hejji, L., Assafi, A., et al. (2026) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2026.132611 · Cited by 2 · see citing works
The application of inflammation-modulating dermal scaffolds in chronic wound repair
Xie, C., Huang, H., Jiang, L., Zheng, Y., & Xia, Z. (2026) · Materials Today Communications · doi:10.1016/j.mtcomm.2026.114757 · Cited by 2 · see citing works
Feng, S., Zhao, J., Li, P., Yang, T., & Li, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117323
Hossain, M. S. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2600024
Applications of polysaccharide hydrogels in wound healing and immune regulation
Jin, A., Zhou, S., Wang, Y., Tang, C., Liu, J., Lei, L., & Shen, G. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152875
Mao, J., Zhang, C., Wang, J., et al. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214838
ANN-Based Prediction of Young’s Modulus in PVA/ Honey Hydrogel Optimized by Taguchi Design
Azmi, N. N., Nazri, N. A. A., Mahmud, J., et al. (2025) · doi:10.1109/icsgrc65918.2025.11159739
Bioresorbable materials in tissue engineering and regeneration: design and applications
Sharma, D., Mishra, A. K., Magani, S. K. J., & Dahiya, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31606-7.00019-3
- Authors
- You, C., Zhu, Z., Wang, S., Wang, X., Han, C., & Shao, H.
- Affiliations
- Second Affiliated Hospital of Zhejiang University (CN)
- The First People's Hospital of Wenling (CN)
- Corresponding author
- Han, Chunmao
- Shao, Huawei
- Venue
- Journal of Zhejiang University SCIENCE B
- Publisher
- Zhejiang University Press
- Published
- 2023-06
- Volume
- 24
- Issue
- 6
- Pages
- 510-523
- ISSN
- 1673-1581 (ISSN-L)
- 1862-1783
- PMC
- PMC10264175
- OpenAlex
- W4380422883
- Cited by
- 20
- References
- 37
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 7
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Journal of Zhejiang University SCIENCE B (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81601681 and 81871558, 81601681, 81871558)
- Topics
- Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
- Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- silver nanoparticles, foreign body reaction, wound healing, macrophage polarization, collagen-chitosan scaffold, tissue engineering scaffolds, M1/M2 macrophage balance, arginase-1, subcutaneous implantation, silver release
- MeSH terms
- Animals, Foreign Bodies, Foreign-Body Reaction, Macrophage Activation, Silver, Swine, Wound Healing, Interleukin-6, Tissue Inhibitor of Metalloproteinase-1, Chitosan, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review